Welcome to the website of the Malaria in Pregnancy (MiP) Consortium. Between 2007 and 2017, a partnership of 47 expert institutions worldwide joined together in pursuit of a consensus research strategy to address the major research gaps in malaria infection during pregnancy.
Annually, as many as 125 million pregnancies occur in malaria endemic countries. Infection with malaria in pregnancy can result in pregnancy loss, maternal death, severe maternal anaemia and low infant birth weight which greatly increases the risk of death.
Malaria in pregnancy is responsible for as many as 100,000 children dying needlessly every year. In sub-Saharan Africa, where malaria is endemic in most countries, severe malaria accounts for approximately 10% of maternal deaths, suggesting that an estimated 25,000 maternal deaths could be prevented each year by improved control of malaria in pregnancy.
The MiP consortium, led by the Liverpool School of Tropical Medicine (LSTM), was established with an initial grant of $31 million from the Bill and Melinda Gates Foundation with co-funding from the European and Developing Countries Clinical Trials Partnership (EDCTP) and the European Union along with other funders.
Some MiP HIghlights